CRMH and CityU Pioneer Neu-001 for Amblyopia Treatment Secures FDA Approval for Clinical Trials December 17, 2024
A delegation led by Lu Fangjun, Deputy Director of the Bureau of science communication, Chinese Academy of sciences, Wang Yifang, Academician of Chinese Academy of Sciences and Director of the Institute of High Energy Physics, Chinese Academy of Sciences, and Zhao Zhentang, Academician of the Chinese Academy of Engineering and Director of the Shanghai Synchrotron Radiation Facility, visited the research center for investigation and research. July 25, 2024
The 13th Guangzhou International Stem Cell and Regenerative Medicine Symposium Successfully Held December 18, 2023
The 4th Annual Meeting of the Max Planck-GIBH Joint Center for Regenerative Biomedicine and the CUHK-MPI-GIBH-CRMH Joint Forum on Stem Cells and Molecular Medicine were successfully held at The Chinese University of Hong Kong (CUHK) Faculty of Biomedical Sciences December 1, 2023
Wang Keqiang Visits Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences and Shenzhen Institute of Advanced Technology September 18, 2023
The Governor of Hainan Province, Liu Xiaoming, and his delegation visited the center for research purposes. September 11, 2023
The Vice Governor of Liaoning Province, Gao Tao, and his delegation visited the center for research purposes August 25, 2023
Liu Weidong, the Deputy Director of the Bureau of International Cooperation,visited the Centre for Regenerative Medicine and Health (CRMH), Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences Chinese Academy of Sciences, March 8, 2023
CRMH and CityU Pioneer Neu-001 for Amblyopia Treatment Secures FDA Approval for Clinical Trials December 17, 2024
A delegation led by Lu Fangjun, Deputy Director of the Bureau of science communication, Chinese Academy of sciences, Wang Yifang, Academician of Chinese Academy of Sciences and Director of the Institute of High Energy Physics, Chinese Academy of Sciences, and Zhao Zhentang, Academician of the Chinese Academy of Engineering and Director of the Shanghai Synchrotron Radiation Facility, visited the research center for investigation and research. July 25, 2024
The 13th Guangzhou International Stem Cell and Regenerative Medicine Symposium Successfully Held December 18, 2023
The 4th Annual Meeting of the Max Planck-GIBH Joint Center for Regenerative Biomedicine and the CUHK-MPI-GIBH-CRMH Joint Forum on Stem Cells and Molecular Medicine were successfully held at The Chinese University of Hong Kong (CUHK) Faculty of Biomedical Sciences December 1, 2023
Wang Keqiang Visits Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences and Shenzhen Institute of Advanced Technology September 18, 2023
The Governor of Hainan Province, Liu Xiaoming, and his delegation visited the center for research purposes. September 11, 2023
The Vice Governor of Liaoning Province, Gao Tao, and his delegation visited the center for research purposes August 25, 2023
Liu Weidong, the Deputy Director of the Bureau of International Cooperation,visited the Centre for Regenerative Medicine and Health (CRMH), Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences Chinese Academy of Sciences, March 8, 2023
A First-of-its-Kind Discovery published on Mol Cancer by the Pei Duanqing Team at Westlake University June 24, 2024
New Progress in the Development of Genetically Engineered Macrophages from Human Pluripotent Stem Cells for Cancer Therapy June 24, 2024
Scientists have discovered two major biomarkers of intestinal aging and revealed the patterns of mitochondrial DNA (mtDNA) mutations in the intestine, which holds promise for developing new candidate drugs March 24, 2024
The Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences has made important progress in human pluripotent stem cell (hPSC) interspecies chimerism technology April 15, 2022
Scientists have discovered the progressive modification pattern of the kinase-mediated heterochromatin structure November 25, 2021
A First-of-its-Kind Discovery published on Mol Cancer by the Pei Duanqing Team at Westlake University June 24, 2024
New Progress in the Development of Genetically Engineered Macrophages from Human Pluripotent Stem Cells for Cancer Therapy June 24, 2024
Scientists have discovered two major biomarkers of intestinal aging and revealed the patterns of mitochondrial DNA (mtDNA) mutations in the intestine, which holds promise for developing new candidate drugs March 24, 2024
The Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences has made important progress in human pluripotent stem cell (hPSC) interspecies chimerism technology April 15, 2022
Scientists have discovered the progressive modification pattern of the kinase-mediated heterochromatin structure November 25, 2021
13th Guangzhou International Symposium on Stem Cells and Regenerative Medicine Third Round Announcement December 1, 2023
13th Guangzhou International Symposium on Stem Cells and Regenerative Medicine Second Round Announcement September 27, 2023
13th Guangzhou International Symposium on Stem Cells and Regenerative Medicine First Round Announcement August 31, 2023
13th Guangzhou International Symposium on Stem Cells and Regenerative Medicine Third Round Announcement December 1, 2023
13th Guangzhou International Symposium on Stem Cells and Regenerative Medicine Second Round Announcement September 27, 2023
13th Guangzhou International Symposium on Stem Cells and Regenerative Medicine First Round Announcement August 31, 2023
